A non-parametric proportional risk model to assess a treatment effect in time-to-event data

03/13/2023
by   Lucia Ameis, et al.
0

Time-to-event analysis often relies on prior parametric assumptions, or, if a non-parametric approach is chosen, Cox's model. This is inherently tied to the assumption of proportional hazards, with the analysis potentially invalidated if this assumption is not fulfilled. In addition, most interpretations focus on the hazard ratio, that is often misinterpreted as the relative risk. In this paper, we introduce an alternative to current methodology for assessing a treatment effect in a two-group situation, not relying on the proportional hazards assumption but assuming proportional risks. Precisely, we propose a new non-parametric model to directly estimate the relative risk of two groups to experience an event under the assumption that the risk ratio is constant over time. In addition to this relative measure, our model allows for calculating the number needed to treat as an absolute measure, providing the possibility of an easy and holistic interpretation of the data. We demonstrate the validity of the approach by means of a simulation study and present an application to data from a large randomized controlled trial investigating the effect of dapagliflozin on the risk of first hospitalization for heart failure.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
09/14/2020

Survival analysis under non-proportional hazards: investigating non-inferiority or equivalence in time-to-event data

The classical approach to analyze time-to-event data, e.g. in clinical t...
research
09/24/2021

The hazard ratio is interpretable as an odds or a probability under the assumption of proportional hazards

Three statistical studies, all published between 2004 and 2008 but witho...
research
03/28/2023

Risk ratio, odds ratio, risk difference... Which causal measure is easier to generalize?

There are many measures to report so-called treatment or causal effect: ...
research
08/31/2021

Comments on The clinical meaningfulness of a treatment's effect on a time-to-event variable

Some years ago, Snapinn and Jiang[1] considered the interpretation and p...
research
07/25/2019

Non-constant hazard ratios in randomized controlled trials with composite endpoints

The hazard ratio is routinely used as a summary measure to assess the tr...
research
08/20/2019

Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group

Loss of power and clear description of treatment differences are key iss...
research
07/09/2020

Non-proportional hazards in immuno-oncology: is an old perspective needed?

A fundamental concept in two-arm non-parametric survival analysis is the...

Please sign up or login with your details

Forgot password? Click here to reset